Search by Drug Name or NDC
NDC 00169-3303-91 NOVOLOG 100 [iU]/mL Details
NOVOLOG 100 [iU]/mL
NOVOLOG is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is INSULIN ASPART.
Product Information
| NDC | 00169-3303 |
|---|---|
| Product ID | 0169-3303_99351c0b-1c32-4eaf-8bc0-68079866d80c |
| Associated GPIs | |
| GCN Sequence Number | 044093 |
| GCN Sequence Number Description | insulin aspart CARTRIDGE 100/ML SUBCUT |
| HIC3 | C4G |
| HIC3 Description | INSULINS |
| GCN | 92886 |
| HICL Sequence Number | 020769 |
| HICL Sequence Number Description | INSULIN ASPART |
| Brand/Generic | Brand |
| Proprietary Name | NOVOLOG |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | insulin aspart |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS; SUBCUTANEOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | [iU]/mL |
| Substance Name | INSULIN ASPART |
| Labeler Name | Novo Nordisk |
| Pharmaceutical Class | Insulin Analog [EPC], Insulin [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA020986 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00169-3303-91 (00169330391)
| NDC Package Code | 0169-3303-91 |
|---|---|
| Billing NDC | 00169330391 |
| Package | 1 CARTRIDGE in 1 CARTON (0169-3303-91) / 3 mL in 1 CARTRIDGE |
| Marketing Start Date | 2001-08-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |